Trial · NCT03068754
Participant flow64
How many started, completed or left each group, period by period.
21 to 40 of 64
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomized Treatment Period (RTP) | Completed 36 Weeks of Treatment | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 28 | |
| Randomized Treatment Period (RTP) | Completed 36 Weeks of Treatment | Arm B: RTP Placebo | 9 | |
| Randomized Treatment Period (RTP) | Completed 36 Weeks of Treatment | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Completed 36 Weeks of Treatment | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Completed RTP | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 27 | |
| Randomized Treatment Period (RTP) | Completed RTP | Arm B: RTP Placebo | 9 | |
| Randomized Treatment Period (RTP) | Completed RTP | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Completed RTP | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Enrolled in OLE Period | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 25 | |
| Randomized Treatment Period (RTP) | Enrolled in OLE Period | Arm B: RTP Placebo | 8 | |
| Randomized Treatment Period (RTP) | Enrolled in OLE Period | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Enrolled in OLE Period | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | COMPLETED | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 28 | |
| Randomized Treatment Period (RTP) | COMPLETED | Arm B: RTP Placebo | 9 | |
| Randomized Treatment Period (RTP) | COMPLETED | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | COMPLETED | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | NOT COMPLETED | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 67 | |
| Randomized Treatment Period (RTP) | NOT COMPLETED | Arm B: RTP Placebo | 39 | |
| Randomized Treatment Period (RTP) | NOT COMPLETED | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | NOT COMPLETED | Arm D: OLE Placebo-Acthar Gel | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03068754/flow?page=2